Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effectiveness and Safety of Elagolix Treatment in Moderate to Severe Endometriosis-associated Pain in Routine Clinical Practice in Israel- ENDORSE Study

NCT04630990 is registered in ClinicalTrials.gov with AbbVie as lead sponsor.

NCT NCT04630990
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04630990 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effectiveness and Safety of Elagolix Treatment in Moderate to Severe Endometriosis-associated Pain in Routine Clinical Practice in Israel- ENDORSE Study
Lead sponsor
AbbVie
Phase
Observational
Overall status
Completed
Start date
December 14, 2020
Completion date
March 26, 2024
Enrollment
117 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

endometriosis